Black Diamond Therapeutics, Inc.
BDTX
$2.58
-$0.11-4.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 135.50M | 142.83M | 152.40M | 98.58M | 112.68M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.49M | 3.90M | 3.28M | 2.60M | 2.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 138.99M | 146.73M | 155.68M | 101.18M | 115.54M |
|
|
|||||
| Total Current Assets | 138.99M | 146.73M | 155.68M | 101.18M | 115.54M |
| Net Property, Plant & Equipment | 17.80M | 18.67M | 19.54M | 20.40M | 21.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 944.00K | 985.00K | 1.03M | 1.07M | 1.12M |
| Total Assets | 157.73M | 166.39M | 176.25M | 122.64M | 137.90M |
|
|
|||||
| Total Accounts Payable | 975.00K | 771.00K | 2.63M | 4.01M | 1.97M |
| Total Accrued Expenses | 10.94M | 12.25M | 10.51M | 13.16M | 15.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.63M | 3.78M | 3.71M | 3.40M | 3.33M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 15.55M | 16.81M | 16.85M | 20.57M | 20.80M |
|
|
|||||
| Total Current Liabilities | 15.55M | 16.81M | 16.85M | 20.57M | 20.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.04M | 16.97M | 17.88M | 18.78M | 19.67M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.58M | 33.78M | 34.73M | 39.36M | 40.47M |
|
|
|||||
| Common Stock & APIC | 575.63M | 573.76M | 572.10M | 570.37M | 568.44M |
| Retained Earnings | -449.62M | -441.13M | -430.57M | -487.11M | -471.12M |
| Treasury Stock & Other | 142.00K | -25.00K | -19.00K | 24.00K | 107.00K |
| Total Common Equity | 126.15M | 132.61M | 141.52M | 83.29M | 97.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 126.15M | 132.61M | 141.52M | 83.29M | 97.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 126.15M | 132.61M | 141.52M | 83.29M | 97.43M |
|
|
|||||